Document is current
Any future updates will be listed below
-
Authors
Schmitz, Katja
Schatz, Christoph
Knabl, Ludwig
- License Information
-
More Information
Article History
Received: 1 May 2024
Accepted: 10 July 2024
First Online: 21 August 2024
Conflict of interest
: K. Schmitz received honoraria as advisor or speaker and/or travel fees from: Amgen, AstraZeneca, Bayer, Daiichi-Sankyo, Diaceutics, Discovery Life Sciences, Incyte, Janssen, Eli Lilly, Merck, Merck Sharp and Dohme, Novartis Pharma, Pfizer, PharmaMar, Roche Pharma, Sanofi, Servier, Stemline, Takeda, Targos GmbH, and ZytoVision. The review is not influenced by sponsoring. C. Schatz and L. Knabl declare that they have no competing interests.
